NCT04284488 2026-01-08Dose-escalation Study of APG-1387 and Toripalimab in Solid TumorsAscentage Pharma Group Inc.Phase 1/2 Terminated40 enrolled
NCT04643405 2026-01-08APG-1387 Plus Chemotherapy in Advanced Pancreatic AdenocarcinomaAscentage Pharma Group Inc.Phase 1/2 Terminated21 enrolled
NCT05109442 2025-08-20Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing CancersAffimed GmbHPhase 1/2 Terminated112 enrolled 28 charts